Package 67184-0523-2

{"route": ["ORAL"], "spl_id": "3c59b310-6a02-451b-bc53-a29022509963", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_set_id": ["f295f164-78fb-4224-b319-9f20b7a453b5"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Qilu Pharmaceutical Co., Ltd."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (67184-0523-1)", "package_ndc": "67184-0523-1", "marketing_start_date": "20211117"}, {"sample": false, "description": "2 BLISTER PACK in 1 CARTON (67184-0523-2)  / 15 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "67184-0523-2", "marketing_start_date": "20211117"}], "brand_name": "Tadalafil", "product_id": "67184-0523_3c59b310-6a02-451b-bc53-a29022509963", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "67184-0523", "generic_name": "Tadalafil", "labeler_name": "Qilu Pharmaceutical Co., Ltd.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "2.5 mg/1"}], "application_number": "ANDA210420", "marketing_category": "ANDA", "marketing_start_date": "20211117", "listing_expiration_date": "20261231"}